Reham Soliman

1.4k total citations
49 papers, 651 citations indexed

About

Reham Soliman is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Reham Soliman has authored 49 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hepatology, 38 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Reham Soliman's work include Hepatitis C virus research (35 papers), Liver Disease Diagnosis and Treatment (32 papers) and Hepatitis B Virus Studies (18 papers). Reham Soliman is often cited by papers focused on Hepatitis C virus research (35 papers), Liver Disease Diagnosis and Treatment (32 papers) and Hepatitis B Virus Studies (18 papers). Reham Soliman collaborates with scholars based in Egypt, United States and Switzerland. Reham Soliman's co-authors include Gamal Shiha, Nabiel Mikhail, Mohamed Elbasiony, Philippa Easterbrook, Mohamed Hassany, Gamal Esmat, Wahid Doss, Ammal M. Metwally, Rabab Fouad and John G. McHutchison and has published in prestigious journals such as Gut, Scientific Reports and Journal of Hepatology.

In The Last Decade

Reham Soliman

42 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reham Soliman Egypt 15 533 517 71 33 25 49 651
Anne Varaut France 8 356 0.7× 383 0.7× 51 0.7× 17 0.5× 14 0.6× 10 446
Jorge Méndez-Navarro United States 11 334 0.6× 387 0.7× 42 0.6× 33 1.0× 19 0.8× 13 564
Stefan Bourgeois Belgium 11 540 1.0× 535 1.0× 124 1.7× 31 0.9× 24 1.0× 49 708
Philip Vutien United States 15 437 0.8× 438 0.8× 41 0.6× 22 0.7× 15 0.6× 51 573
Henrique Sergio Coelho Brazil 11 410 0.8× 382 0.7× 63 0.9× 40 1.2× 21 0.8× 19 558
Kenneth Hirsch United States 10 362 0.7× 400 0.8× 101 1.4× 51 1.5× 11 0.4× 20 539
G.B. Gaeta Italy 14 355 0.7× 329 0.6× 46 0.6× 25 0.8× 55 2.2× 44 505
Minoru Ayada Japan 12 268 0.5× 170 0.3× 81 1.1× 21 0.6× 13 0.5× 22 432
Premashish Kar India 11 255 0.5× 150 0.3× 73 1.0× 45 1.4× 14 0.6× 32 402
Steven Shev Sweden 10 360 0.7× 359 0.7× 51 0.7× 45 1.4× 22 0.9× 11 453

Countries citing papers authored by Reham Soliman

Since Specialization
Citations

This map shows the geographic impact of Reham Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reham Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reham Soliman more than expected).

Fields of papers citing papers by Reham Soliman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reham Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reham Soliman. The network helps show where Reham Soliman may publish in the future.

Co-authorship network of co-authors of Reham Soliman

This figure shows the co-authorship network connecting the top 25 collaborators of Reham Soliman. A scholar is included among the top collaborators of Reham Soliman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reham Soliman. Reham Soliman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiha, Gamal, et al.. (2025). Long Term Clinical Outcomes in Chronic Hepatitis C Patients Who Achieved SVR Following DAA s: A Decade Long Prospective Study. Journal of Viral Hepatitis. 32(7). e70044–e70044.
3.
Dorival, Céline, Carole Cagnot, Hélène Fontaine, et al.. (2022). Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response. Clinics and Research in Hepatology and Gastroenterology. 46(6). 101923–101923. 14 indexed citations
5.
Reipold, Elena Ivanova, Reham Soliman, Muhammad S. Jamil, et al.. (2021). Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt. BMC Public Health. 21(1). 1188–1188. 19 indexed citations
6.
Nabil, Ahmed, Koichiro Uto, Faten Zahran, et al.. (2021). The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs. BioMed Research International. 2021(1). 6678913–6678913. 8 indexed citations
7.
Lotfy, Ahmed, et al.. (2021). Stem cell therapies for autoimmune hepatitis. Stem Cell Research & Therapy. 12(1). 386–386. 14 indexed citations
8.
Shiha, Gamal, Reham Soliman, Mohamed Elbasiony, Noureldien H. E. Darwish, & Shaker A. Mousa. (2021). Novel combined single dose anti-hepatitis C therapy: a pilot study. Scientific Reports. 11(1). 4623–4623. 2 indexed citations
10.
Shiha, Gamal, Reham Soliman, Nabiel Mikhail, & Philippa Easterbrook. (2020). Reduced incidence of hepatitis C in 9 villages in rural Egypt: Progress towards national elimination goals. Journal of Hepatology. 74(2). 303–311. 13 indexed citations
11.
Shiha, Gamal, Reham Soliman, Mohamed Elbasiony, Noureldien H. E. Darwish, & Shaker A. Mousa. (2019). Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot Study. Scientific Reports. 9(1). 13593–13593. 11 indexed citations
12.
Wang, Jianing, Philippa Easterbrook, C. Robert Horsburgh, et al.. (2019). Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset. Journal of Hepatology. 71(1). 62–70. 25 indexed citations
13.
Shiha, Gamal, Reham Soliman, Nabiel Mikhail, & Philippa Easterbrook. (2019). An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages. Journal of Hepatology. 72(4). 658–669. 32 indexed citations
14.
Donia, Ahmed Farouk, et al.. (2019). Treatment of Chronic Hepatitis C Infection Among Egyptian Kidney Transplant Recipients: A Pilot Study. PubMed. 17(Suppl 1). 62–67. 1 indexed citations
15.
Shiha, Gamal, et al.. (2018). Chronic Hepatitis C Patients with Obesity: Do We Need Two Operators for Accurate Evaluation of Liver Stiffness?. Annals of Hepatology. 17(5). 795–801. 8 indexed citations
16.
17.
Shiha, Gamal, et al.. (2018). Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience. Hepatology International. 12(4). 339–347. 25 indexed citations
18.
Shiha, Gamal, Ammal M. Metwally, Reham Soliman, et al.. (2018). An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project. ˜The œLancet. Gastroenterology & hepatology. 3(11). 778–789. 46 indexed citations
20.
Doss, Wahid, Gamal Shiha, Mohamed Hassany, et al.. (2015). Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4. Journal of Hepatology. 63(3). 581–585. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026